Koninklijke Philips EBITDA Margin 2010-2025 | PHG

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Koninklijke Philips (PHG) over the last 10 years. The current EBITDA margin for Koninklijke Philips as of March 31, 2025 is .
Koninklijke Philips EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $18.47B $0.95B 5.14%
2024-06-30 $18.60B $0.51B 2.73%
2023-06-30 $18.89B $-0.27B -1.43%
2023-03-31 $18.85B $-0.26B -1.38%
2022-06-30 $19.63B $0.76B 3.86%
2021-06-30 $20.30B $1.10B 5.42%
2020-06-30 $19.93B $1.28B 6.41%
2019-06-30 $22.93B $2.31B 10.08%
2018-06-30 $24.26B $2.79B 11.49%
2017-06-30 $25.77B $3.21B 12.45%
2016-12-31 $27.13B $3.52B 12.96%
2016-09-30 $27.08B $2.85B 10.52%
2016-06-30 $26.99B $2.71B 10.05%
2016-03-31 $26.98B $2.69B 9.96%
2015-12-31 $26.92B $2.58B 9.57%
2015-09-30 $26.06B $2.33B 8.93%
2015-06-30 $26.93B $1.87B 6.94%
2015-03-31 $27.58B $1.99B 7.21%
2014-12-31 $28.44B $2.25B 7.92%
2014-09-30 $30.72B $3.43B 11.16%
2014-06-30 $30.80B $4.22B 13.70%
2014-03-31 $30.92B $4.42B 14.29%
2013-12-31 $30.99B $4.49B 14.48%
2013-09-30 $31.41B $3.60B 11.45%
2013-06-30 $31.96B $3.69B 11.56%
2013-03-31 $31.77B $3.26B 10.27%
2012-12-31 $32.19B $3.49B 10.85%
2012-09-30 $31.35B $3.44B 10.98%
2012-06-30 $30.80B $2.90B 9.41%
2012-03-31 $31.11B $3.13B 10.04%
2011-12-31 $31.33B $3.36B 10.71%
2011-09-30 $32.59B $4.29B 13.15%
2011-06-30 $33.09B $4.76B 14.39%
2011-03-31 $33.49B $4.82B 14.40%
2010-12-31 $33.77B $4.55B 13.47%
2010-09-30 $34.44B $5.85B 16.97%
2010-06-30 $34.60B $5.79B 16.74%
2010-03-31 $34.14B $4.21B 12.33%
2009-12-31 $32.91B $3.40B 10.32%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $22.051B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.407B 27.95
Boston Scientific (BSX) United States $151.037B 37.81
Stryker (SYK) United States $146.527B 30.64
EssilorLuxottica (ESLOY) France $129.703B 0.00
Medtronic (MDT) Ireland $112.146B 15.90
Lonza Group Ag (LZAGY) Switzerland $50.313B 0.00
Haleon (HLN) United Kingdom $49.826B 28.39
ResMed (RMD) United States $36.979B 27.77
Agilent Technologies (A) United States $32.895B 21.44
GE HealthCare Technologies (GEHC) United States $32.794B 15.57
Terumo (TRUMY) Japan $26.561B 34.50
Insulet (PODD) United States $21.941B 86.12
Zimmer Biomet Holdings (ZBH) United States $18.277B 11.74
Baxter (BAX) United States $15.529B 11.59
Smith & Nephew SNATS (SNN) United Kingdom $13.253B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Sunny Optical Technology (SNPTF) China $8.430B 0.00
Bio-Rad Laboratories (BIO) United States $5.971B 20.78
Lantheus Holdings (LNTH) United States $5.642B 14.23
Prestige Consumer Healthcare (PBH) United States $4.203B 18.78
Perrigo (PRGO) Ireland $3.596B 9.11
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.385B 15.42
ICU Medical (ICUI) United States $3.275B 24.15
Envista Holdings (NVST) United States $3.174B 26.38
GN Store Nord (GNNDY) Denmark $2.180B 18.06
QuidelOrtho (QDEL) United States $1.997B 13.73
LeMaitre Vascular (LMAT) United States $1.901B 42.49
AtriCure (ATRC) United States $1.730B 0.00
Acuren (TIC) United States $1.271B 0.00
AdaptHealth (AHCO) United States $1.201B 12.19
Neogen (NEOG) United States $1.131B 14.47
BioLife Solutions (BLFS) United States $1.126B 0.00
Green Thumb Industries (GTBIF) United States $1.100B 24.74
Kestra Medical Technologies (KMTS) United States $1.063B 0.00
Phibro Animal Health (PAHC) United States $0.976B 12.48
InMode (INMD) Israel $0.895B 9.02
Capricor Therapeutics (CAPR) United States $0.650B 0.00
Evolus (EOLS) United States $0.647B 0.00
CeriBell (CBLL) United States $0.647B 0.00
Owens & Minor (OMI) United States $0.619B 5.13
Maravai LifeSciences Holdings (MRVI) United States $0.609B 0.00
Curaleaf Holdings (CURLF) Canada $0.584B 0.00
Valneva SE (VALN) France $0.524B 0.00
Surmodics (SRDX) United States $0.420B 0.00
Tilray Brands (TLRY) Canada $0.408B 0.00
VAREX IMAGING (VREX) United States $0.347B 12.76
SNDL (SNDL) Canada $0.347B 0.00
Aurora Cannabis (ACB) Canada $0.322B 57.20
Canopy Growth (CGC) Canada $0.313B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.291B 0.00
Cerus (CERS) United States $0.289B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.40
Cresco Labs (CRLBF) United States $0.265B 0.00
Sanara MedTech (SMTI) United States $0.262B 0.00
ZimVie (ZIMV) United States $0.261B 11.87
Sanuwave Health (SNWV) United States $0.239B 0.00
Omeros (OMER) United States $0.221B 0.00
OraSure Technologies (OSUR) United States $0.216B 0.00
Biote (BTMD) United States $0.210B 5.89
Quanterix (QTRX) United States $0.209B 0.00
TriSalus Life Sciences (TLSI) United States $0.204B 0.00
Brainsway (BWAY) Israel $0.197B 52.25
High Tide (HITI) Canada $0.193B 0.00
Verano Holdings (VRNOF) United States $0.192B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.86
Organigram Global (OGI) Canada $0.181B 0.00
Exagen (XGN) United States $0.154B 0.00
Vireo Growth (VREOF) United States $0.139B 0.00
FitLife Brands (FTLF) United States $0.134B 0.00
Jin Medical (ZJYL) China $0.120B 0.00
MacroGenics (MGNX) United States $0.112B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Veru (VERU) United States $0.091B 0.00
Fonar (FONR) United States $0.090B 11.59
Quipt Home Medical (QIPT) United States $0.087B 0.00
TerrAscend (TSNDF) Canada $0.082B 0.00
Agape ATP (ATPC) $0.077B 0.00
InterCure (INCR) Israel $0.068B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Apyx Medical (APYX) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.058B 0.00
Modular Medical (MODD) United States $0.046B 0.00
United-Guardian (UG) United States $0.038B 13.14
Nephros (NEPH) United States $0.036B 48.00
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Meihua Medical Technologies (MHUA) China $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.017B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00